-
-
-
-
-
-
-
Arena Reports Third Quarter Financial Results and Key Program Updates
-
-
-
-
-
-
-
Arena Pharma (ARNA) Tops Q1 EPS by 18c
-
-
-
-
-
-
-
Arena Reports Third Quarter Financial Results with Strong Cash Position, Advancing Etrasimod Into a Phase 3 Registrational Program in Atopic Dermatitis
-
-
-
-
-
-
-
Arena Pharmaceuticals to Release First Quarter 2020 Financial Results and Provide Corporate Update on May 7
-
-
-
-
-
-
-
Arena Pharma (ARNA) Misses Q2 EPS by 16c
-
-
-
-
-
-
-
Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
-
-
-
-
-
-
-
Arena Pharma (ARNA) Misses Q2 EPS by 1c
-
972,881 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All